ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants

Phase 3
Active, not recruiting
Conditions
Interventions
First Posted Date
2022-07-11
Last Posted Date
2024-06-20
Lead Sponsor
Allergan
Target Recruit Count
171
Registration Number
NCT05452070
Locations
🇨🇦

Humphrey & Beleznay Cosmetic Dermatology /ID# 239805, Vancouver, British Columbia, Canada

🇨🇦

Dermetics Cosmetic Dermatology /ID# 246536, Burlington, Ontario, Canada

🇨🇦

The Centre for Clinical Trials /ID# 246409, Oakville, Ontario, Canada

and more 9 locations

Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2022-05-26
Last Posted Date
2022-06-29
Lead Sponsor
Allergan
Registration Number
NCT05393089
Locations
🇺🇸

Global Research Management /ID# 243544, Glendale, California, United States

🇺🇸

United Medical Research Institute /ID# 243531, Inglewood, California, United States

🇺🇸

Salvay Vision /ID# 243828, Newport Beach, California, United States

and more 29 locations

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines

Phase 3
Completed
Conditions
Interventions
First Posted Date
2022-02-21
Last Posted Date
2024-01-10
Lead Sponsor
Allergan
Target Recruit Count
309
Registration Number
NCT05248880
Locations
🇨🇦

YVR Aesthetics Training & Study Centre /ID# 241858, Vancouver, British Columbia, Canada

🇺🇸

Delricht Research - 10154 Jefferson /ID# 244890, Baton Rouge, Louisiana, United States

🇺🇸

DMR Research PLLC /ID# 239061, Westport, Connecticut, United States

and more 14 locations

A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines

Phase 2
Completed
Conditions
Interventions
First Posted Date
2021-12-10
Last Posted Date
2023-08-14
Lead Sponsor
Allergan
Target Recruit Count
124
Registration Number
NCT05152576
Locations
🇺🇸

The Center for Dermatology Cosmetics & Laser Surgery /ID# 239776, Mount Kisco, New York, United States

🇺🇸

Dermatology Consulting Service /ID# 239779, High Point, North Carolina, United States

🇺🇸

Steve Yoelin MD Medical Assoc. Inc /ID# 239771, Newport Beach, California, United States

and more 5 locations

Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

First Posted Date
2021-12-02
Last Posted Date
2024-07-23
Lead Sponsor
Allergan
Target Recruit Count
83
Registration Number
NCT05141006
Locations
🇺🇸

Alliance for Multispecialty Research (AMR) - Mobile /ID# 241002, Mobile, Alabama, United States

🇺🇸

Urology Centers of Alabama /ID# 243600, Homewood, Alabama, United States

🇺🇸

Sun Kim Urology /ID# 257566, Buena Park, California, United States

and more 40 locations

HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation

Phase 4
Completed
Conditions
Interventions
First Posted Date
2021-11-15
Last Posted Date
2023-10-05
Lead Sponsor
Allergan
Target Recruit Count
140
Registration Number
NCT05119777
Locations
🇫🇷

Eurofins Dermscan Pharmascan /ID# 240921, Aix-en-Provence, France

🇫🇷

Eurofins Pharmascan /ID# 240920, Lyon, France

A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Phase 2
Completed
Conditions
Interventions
First Posted Date
2021-10-29
Last Posted Date
2023-11-07
Lead Sponsor
Allergan
Target Recruit Count
328
Registration Number
NCT05100199
Locations
🇺🇸

Coleman Center For Cosmetic Dermatologic Surgery /ID# 230693, Metairie, Louisiana, United States

🇺🇸

Etre Cosmetic Dermatology and Laser Center /ID# 230437, New Orleans, Louisiana, United States

🇺🇸

The Eye Research Foundation /ID# 232544, Newport Beach, California, United States

and more 15 locations

Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult Participants

Phase 3
Completed
Conditions
Interventions
First Posted Date
2021-10-22
Last Posted Date
2024-11-25
Lead Sponsor
Allergan
Target Recruit Count
160
Registration Number
NCT05088980
Locations
🇨🇳

Zhongda Hospital Southeast University /ID# 241040, Nanjing, Jiangsu, China

🇨🇳

Nanjing Drum Tower Hospital /ID# 241042, Nanjing, Jiangsu, China

🇨🇳

Peking University First Hospital /ID# 227593, Xicheng District, Beijing, China

and more 4 locations

VFORM: Prospective, Open Label, Study to Evaluate VOLIFT With Lidocaine Treatment for FORehead Contouring and Marionette Lines

First Posted Date
2021-10-14
Last Posted Date
2022-11-30
Lead Sponsor
Allergan
Target Recruit Count
163
Registration Number
NCT05077488
Locations
🇫🇷

Eurofins Pharmascan /ID# 243454, Lyon, France

A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Phase 2
Completed
Conditions
Interventions
First Posted Date
2021-08-19
Last Posted Date
2023-06-13
Lead Sponsor
Allergan
Target Recruit Count
92
Registration Number
NCT05013424
Locations
🇺🇸

Etre Cosmetic Dermatology and Laser Center /ID# 227365, New Orleans, Louisiana, United States

🇺🇸

Advanced Research Associates - Glendale /ID# 227368, Glendale, Arizona, United States

🇺🇸

Austin Institute for Clinical Research /ID# 227367, Pflugerville, Texas, United States

and more 2 locations
© Copyright 2024. All Rights Reserved by MedPath